Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment (HAE)

5 mins read

This has been a challenging year for the medical device sector, In addition to ongoing worries about reimbursement and a lack of innovation, investors have also fretted about the impact of GLP-1 drugs on a host

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

Austin and Blinken pledge fulsome support for Israel as concerns about expected ground offensive grow

Next Story

Oil and gas prices are climbing again as supply risks multiply

Latest from News